HRT Financial’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-49,940
Closed -$494K 3636
2022
Q3
$494K Hold
49,940
0.01% 1591
2022
Q2
$491K Hold
49,940
0.01% 1632
2022
Q1
$495K Hold
49,940
﹤0.01% 1785
2021
Q4
$503K Hold
49,940
﹤0.01% 1762
2021
Q3
$499K Hold
49,940
﹤0.01% 1986
2021
Q2
$497K Hold
49,940
﹤0.01% 1786
2021
Q1
$494K Buy
+49,940
New +$507K 0.01% 1797

HRT Financial's EQHA.U Position: Q4 2022 in Review

HRT Financial sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2022, closing a stake of 49,940 shares — an estimated $494K sold.

HRT Financial first reported a position in EQHA.U in Q1 2021 and held it in 7 quarters. The position peaked at $503K in Q4 2021. 0 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2022.

  • HRT Financial reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 49,940 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2022, an estimated $494K.
  • HRT Financial first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 7 quarters.
  • HRT Financial's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $503K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.